ArticleScientific reports2025
Medication reconciliation and drug interactions in adult cystic fibrosis patients attending an outpatient clinic: A Cross-sectional study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Outpatient medication reconciliation (MR) studies in adult cystic fibrosis (CF) patients are scarce. This project aims to evaluate outpatient MR in adult CF individuals and to identify the prevalence of discrepancies and describe associated factors. Additionally, the study examines drug-drug interactions (DDI) and challenges in accessing medications. It's a cross-sectional study with prospective data collection, involving 65 participants. The sample was divided into two groups based on discrepancies: Group 1 (0-1 discrepancy) included 26 (40%) individuals, and Group 2 (2 or more discrepancies) had 39 (60%). The median number of medications used was 9. Thirty-five patients (53.8%) used medications prescribed only by the CF outpatient clinic, while 30 (46.2%) also had external prescriptions. Fifty-two patients (80%) engaged in self-medication. The number of medications was significantly higher in Group 2 than in Group 1 (median of 11.0 vs. 7.5, p = 0.003). Self-medication was more common in Group 2 (92.3% vs. 61.5%, p = 0.006). Fourteen patients (21.5%) had serious DDIs (type X), and 26 (40%) had type D DDIs. External prescriptions were significantly associated with serious DDIs. Most patients reported difficulty accessing medications. A high prevalence of discrepancies (83%) was observed, linked to the number of medications and self-medication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.